SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-024247
Filing Date
2023-08-21
Accepted
2023-08-21 12:47:13
Documents
43
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnpx20230630_10q.htm   iXBRL 10-Q 733258
2 EXHIBIT 31.1 ex_531768.htm EX-31.1 16183
3 EXHIBIT 31.2 ex_531769.htm EX-31.2 14585
4 EXHIBIT 32.1 ex_531770.htm EX-32.1 10206
  Complete submission text file 0001437749-23-024247.txt   3815168

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20230630.xsd EX-101.SCH 36178
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnpx-20230630_cal.xml EX-101.CAL 18000
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20230630_def.xml EX-101.DEF 264451
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20230630_lab.xml EX-101.LAB 241224
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20230630_pre.xml EX-101.PRE 281063
37 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20230630_10q_htm.xml XML 466119
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38244 | Film No.: 231188312
SIC: 2834 Pharmaceutical Preparations